Abatacept
The risk or severity of infection can be increased when Certolizumab pegol is combined with Abatacept.
Adalimumab
The risk or severity of infection can be increased when Adalimumab is combined with Certolizumab pegol.
Anakinra
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Anakinra.
Advertisement
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Certolizumab pegol.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Anthrax immune globulin human.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Certolizumab pegol.
Advertisement
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Bacillus calmette-guerin substrain tice live antigen.
Belimumab
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Belimumab.
Advertisement
Canakinumab
The risk or severity of infection and neutropenia can be increased when Certolizumab pegol is combined with Canakinumab.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Certolizumab pegol.
Etanercept
The risk or severity of infection can be increased when Etanercept is combined with Certolizumab pegol.
Fingolimod
Certolizumab pegol may increase the immunosuppressive activities of Fingolimod.
Golimumab
The risk or severity of infection can be increased when Golimumab is combined with Certolizumab pegol.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Hepatitis B Vaccine (Recombinant).
Infliximab
The risk or severity of infection can be increased when Infliximab is combined with Certolizumab pegol.
Infliximab-Abda
The risk or severity of infection can be increased when Infliximab is combined with Certolizumab pegol.
Infliximab-Dyyb
The risk or severity of infection can be increased when Infliximab is combined with Certolizumab pegol.
Leflunomide
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Leflunomide.
Natalizumab
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Natalizumab.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Certolizumab pegol.
Pegloticase
The therapeutic efficacy of Certolizumab pegol can be decreased when used in combination with Pegloticase.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Certolizumab pegol.
Pirfenidone
The risk or severity of infection can be increased when Pirfenidone is combined with Certolizumab pegol.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Rabies virus inactivated antigen, A.
Rilonacept
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Rilonacept.
Rituximab
Rituximab may increase the immunosuppressive activities of Certolizumab pegol.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Certolizumab pegol.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Rotavirus Vaccine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Rubella virus vaccine.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Salmonella typhi ty21a live antigen.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Certolizumab pegol.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Certolizumab pegol.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Certolizumab pegol.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Tocilizumab
Tocilizumab may increase the immunosuppressive activities of Certolizumab pegol.
Tofacitinib
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Tofacitinib.
Trastuzumab
Trastuzumab may increase the neutropenic activities of Certolizumab pegol.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Varicella Zoster Vaccine (Live/Attenuated).
Vedolizumab
The risk or severity of infection can be increased when Certolizumab pegol is combined with Vedolizumab.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Yellow Fever Vaccine.
